NTRB (Nutriband) ROCE %: -77.17% (As of Apr. 2026)


NTRB Nutriband Inc NTRB
61 GF Score
Price $3.06
GF Value $3.25
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nutriband ROCE %?

Nutriband NTRB -0.33% 61 ROCE % is -77.17% as of Apr. 2026. GuruFocus rates NTRB with a GF Score™ of 61/100 and a GF Value™ of $3.25 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nutriband's annualized ROCE % for the quarter that ended in Apr. 2026 was -77.17%.

Nutriband  (NAS:NTRB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nutriband ROCE % Related Terms

Nutriband ROCE % Historical Data

* Premium members only.

The historical data trend for Nutriband's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutriband ROCE % Chart

Nutriband Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -62.72 -43.30 -71.05 -160.88 -123.87

Nutriband Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -94.45 -115.38 -190.36 -53.46 -77.17
NTRB
61GF Score
Nutriband Inc NTRB
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutriband ROCE % Calculation

Nutriband's annualized ROCE % for the fiscal year that ended in Jan. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jan. 2026 )  (A: Jan. 2025 )(A: Jan. 2026 )
=-8.207/( ( (7.47 - 0.983) + (7.548 - 0.784) )/ 2 )
=-8.207/( (6.487+6.764)/ 2 )
=-8.207/6.6255
=-123.87 %

Nutriband's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2026 )  (Q: Jan. 2026 )(Q: Apr. 2026 )
=-4.948/( ( (7.548 - 0.784) + (6.892 - 0.832) )/ 2 )
=-4.948/( ( 6.764 + 6.06 )/ 2 )
=-4.948/6.412
=-77.17 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -77.17% mean?
Nutriband (NTRB) has a ROCE % of -77.17% as of Apr. 2026.
Is Nutriband's ROCE % too high?
Nutriband's current ROCE % is -77.17%. Overall, Nutriband has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's ROCE % compare to KALA and RNXT?
Nutriband's ROCE % of -77.17% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Nutriband's current ROCE % is -77.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.25, compared to a current price of $3.06 — trading 5.8% below its estimated fair value. The current ROCE % is -77.17%. Nutriband's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Nutriband (NTRB), the current ROCE % is -77.17% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutriband (NTRB) Overvalued in 2026?

Based on GuruFocus' analysis, Nutriband stock appears to be undervalued. The current stock price of $3.06 is trading 5.8% below its estimated GF Value™ of $3.25. GuruFocus considers Nutriband to be Fairly Valued.

Key valuation signals for NTRB:

  • ROCE %: -77.17%
  • GF Value™: $3.25 vs. price of $3.06 (5.8% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutriband Business Description

Address 121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
61GF Score

Get the complete analysis for NTRB

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.06
Price
$3.25
GF Value